KLK3 and prostate carcinoma: To our knowledge, cultural differences in PSA test use have not been widely explored, nevertheless, until there is clear evidence from randomised controlled trials as to whether screening with PSA testing reduces prostate cancer mortality, the implications of a lower than average use of PSA testing are not known.